Stock detail
Alnylam Pharmaceuticals, Inc (ALNY) stock price, chart, and key data
View Alnylam Pharmaceuticals, Inc stock price, chart movement, and headline metrics on Woodstock's stock detail page.
Stock detail
Alnylam Pharmaceuticals, Inc
ALNY · XNAS
$174.00
0.00%
$0.00
Pre-market $175.80 (+1.03%)
Key metrics
52-week range
$9.50 - $13.00
Close price
$174.00
Market cap
$23.3B
P/E ratio
29.59
Beta
1.24
About the company
Alnylam Pharmaceuticals, Inc
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list.
Analyst rating summary
A current read on analyst sentiment from the insight feed.
Mean target
$363
19
Buy
/ 24
Recent calls
10/28/2026
H.C. Wainwright
Patrick Trucchio
Buy · Price target $455
10/27/2026
Guggenheim
Unknown Analyst
Hold
10/27/2026
BMO Capital
David Lebowitz
Buy · Price target $318
24/5 Trading
Act on the stock when the timing works for you.
With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.
*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.
Download the app